Shopping Cart 0
Cart Subtotal
USD 0

Cardiovascular Systems Inc (CSII) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Cardiovascular Systems Inc Company Overview

Cardiovascular Systems Inc Company Snapshot

Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview

Cardiovascular Systems Inc-Pipeline Analysis Overview

Cardiovascular Systems Inc-Key Facts

Cardiovascular Systems Inc-Major Products and Services

Cardiovascular Systems Inc Pipeline Products by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc Pipeline Products Overview

Diamondback 360 Peripheral Orbital Atherectomy System

Diamondback 360 Peripheral Orbital Atherectomy System Product Overview

Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial

Second Generation Diamondback 360 Coronary Orbital Atherectomy System

Second Generation Diamondback 360 Coronary Orbital Atherectomy System Product Overview

Second Generation Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial

ZILIENT Guidewire-Coronary Intervention

ZILIENT Guidewire-Coronary Intervention Product Overview

ZILIENT Guidewire-Radial Peripheral Intervention

ZILIENT Guidewire-Radial Peripheral Intervention Product Overview

Cardiovascular Systems Inc-Key Competitors

Cardiovascular Systems Inc-Key Employees

Cardiovascular Systems Inc-Key Employee Biographies

Cardiovascular Systems Inc-Locations And Subsidiaries

Head Office

Recent Developments

Cardiovascular Systems Inc, Recent Developments

Aug 16, 2019: Cardiovascular Systems presents LIBERTY 360 three-year outcomes at 2019 Amputation Prevention Symposium

Aug 12, 2019: Cardiovascular Systems, to feature LIBERTY 360 three-year outcomes data at 2019 Amputation Prevention Symposium

Aug 06, 2019: Cardiovascular Systems reports fiscal 2019 fourth-quarter financial results

Jul 25, 2019: Cardiovascular Systems announces former U.S. congressman Erik Paulsen joins board of directors

Jun 11, 2019: Cardiovascular Systems announces first patient enroled in REACH PVI Clinical Study

May 01, 2019: Cardiovascular Systems reports fiscal 2019 third-quarter financial results

Jan 30, 2019: Cardiovascular Systems reports fiscal 2019 second-quarter financial results

Jan 16, 2019: First patients in the Middle East treated with Cardiovascular Systems. Diamondback 360 Coronary Orbital Atherectomy System

Jan 07, 2019: Cardiovascular Systems Announces Preliminary Fiscal 2019 Second-Quarter Revenues of USD 60.2 Million

Jan 02, 2019: Cardiovascular Systems Receives Approval for the Diamondback 360 Coronary Orbital Atherectomy System with Classic Crown and New ViperWire Advance FlexTip Guidewire in Japan

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cardiovascular Systems Inc Pipeline Products by Equipment Type

Cardiovascular Systems Inc Pipeline Products by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview

Cardiovascular Systems Inc Pipeline Products by Equipment Type

Cardiovascular Systems Inc Pipeline Products by Indication

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc, Key Facts

Cardiovascular Systems Inc, Major Products and Services

Cardiovascular Systems Inc Number of Pipeline Products by Development Stage

Cardiovascular Systems Inc Pipeline Products Summary by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc Ongoing Clinical Trials Summary

Diamondback 360 Peripheral Orbital Atherectomy System-Product Status

Diamondback 360 Peripheral Orbital Atherectomy System-Product Description

Diamondback 360 Peripheral Orbital Atherectomy System-Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound

Diamondback 360 Peripheral Orbital Atherectomy System-Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions-A Pilot Study

Diamondback 360 Peripheral Orbital Atherectomy System-Radial Access for Navigation to Your Chosen Lesion for Peripheral Vascular Intervention: REACH PVI

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Product Status

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Product Description

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial

ZILIENT Guidewire-Coronary Intervention-Product Status

ZILIENT Guidewire-Coronary Intervention-Product Description

ZILIENT Guidewire-Radial Peripheral Intervention-Product Status

ZILIENT Guidewire-Radial Peripheral Intervention-Product Description

Cardiovascular Systems Inc, Key Employees

Cardiovascular Systems Inc, Key Employee Biographies

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Cardiovascular Systems Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Cook Medical Inc

Spectranetics Corp

Shockwave Medical Inc

Becton Dickinson and Co

Avinger Inc

Medtronic Plc

Boston Scientific Corp

Ra Medical Systems Inc

Johnson & Johnson

Abbott Laboratories

Company Profile

Company Profile Title

Summary

Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for occlusive atherosclerotic disease in peripheralarteries and stenotic material from artificial arteriovenous dialysis fistulae. CSI offers accessories such as guide wire, lubricant, pump and tape. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Cardiovascular Systems Inc Company Overview

Cardiovascular Systems Inc Company Snapshot

Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview

Cardiovascular Systems Inc-Pipeline Analysis Overview

Cardiovascular Systems Inc-Key Facts

Cardiovascular Systems Inc-Major Products and Services

Cardiovascular Systems Inc Pipeline Products by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc Pipeline Products Overview

Diamondback 360 Peripheral Orbital Atherectomy System

Diamondback 360 Peripheral Orbital Atherectomy System Product Overview

Diamondback 360 Peripheral Orbital Atherectomy System Clinical Trial

Second Generation Diamondback 360 Coronary Orbital Atherectomy System

Second Generation Diamondback 360 Coronary Orbital Atherectomy System Product Overview

Second Generation Diamondback 360 Coronary Orbital Atherectomy System Clinical Trial

ZILIENT Guidewire-Coronary Intervention

ZILIENT Guidewire-Coronary Intervention Product Overview

ZILIENT Guidewire-Radial Peripheral Intervention

ZILIENT Guidewire-Radial Peripheral Intervention Product Overview

Cardiovascular Systems Inc-Key Competitors

Cardiovascular Systems Inc-Key Employees

Cardiovascular Systems Inc-Key Employee Biographies

Cardiovascular Systems Inc-Locations And Subsidiaries

Head Office

Recent Developments

Cardiovascular Systems Inc, Recent Developments

Aug 16, 2019: Cardiovascular Systems presents LIBERTY 360 three-year outcomes at 2019 Amputation Prevention Symposium

Aug 12, 2019: Cardiovascular Systems, to feature LIBERTY 360 three-year outcomes data at 2019 Amputation Prevention Symposium

Aug 06, 2019: Cardiovascular Systems reports fiscal 2019 fourth-quarter financial results

Jul 25, 2019: Cardiovascular Systems announces former U.S. congressman Erik Paulsen joins board of directors

Jun 11, 2019: Cardiovascular Systems announces first patient enroled in REACH PVI Clinical Study

May 01, 2019: Cardiovascular Systems reports fiscal 2019 third-quarter financial results

Jan 30, 2019: Cardiovascular Systems reports fiscal 2019 second-quarter financial results

Jan 16, 2019: First patients in the Middle East treated with Cardiovascular Systems. Diamondback 360 Coronary Orbital Atherectomy System

Jan 07, 2019: Cardiovascular Systems Announces Preliminary Fiscal 2019 Second-Quarter Revenues of USD 60.2 Million

Jan 02, 2019: Cardiovascular Systems Receives Approval for the Diamondback 360 Coronary Orbital Atherectomy System with Classic Crown and New ViperWire Advance FlexTip Guidewire in Japan

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cardiovascular Systems Inc Pipeline Products by Equipment Type

Cardiovascular Systems Inc Pipeline Products by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview

Cardiovascular Systems Inc Pipeline Products by Equipment Type

Cardiovascular Systems Inc Pipeline Products by Indication

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc, Key Facts

Cardiovascular Systems Inc, Major Products and Services

Cardiovascular Systems Inc Number of Pipeline Products by Development Stage

Cardiovascular Systems Inc Pipeline Products Summary by Development Stage

Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Cardiovascular Systems Inc Ongoing Clinical Trials Summary

Diamondback 360 Peripheral Orbital Atherectomy System-Product Status

Diamondback 360 Peripheral Orbital Atherectomy System-Product Description

Diamondback 360 Peripheral Orbital Atherectomy System-Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound

Diamondback 360 Peripheral Orbital Atherectomy System-Orbital Vessel Preparation to Maximize DCB Efficacy in Calcified below the Knee (BTK) Lesions-A Pilot Study

Diamondback 360 Peripheral Orbital Atherectomy System-Radial Access for Navigation to Your Chosen Lesion for Peripheral Vascular Intervention: REACH PVI

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Product Status

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Product Description

Second Generation Diamondback 360 Coronary Orbital Atherectomy System-Evaluation of Treatment Strategies for Severe CalcIfic Coronary Arteries: Orbital Atherectomy versus Conventional Angioplasty Technique Prior to Implantation of Drug-eluting Stents: The ECLIPSE Trial

ZILIENT Guidewire-Coronary Intervention-Product Status

ZILIENT Guidewire-Coronary Intervention-Product Description

ZILIENT Guidewire-Radial Peripheral Intervention-Product Status

ZILIENT Guidewire-Radial Peripheral Intervention-Product Description

Cardiovascular Systems Inc, Key Employees

Cardiovascular Systems Inc, Key Employee Biographies

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Cardiovascular Systems Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Cook Medical Inc

Spectranetics Corp

Shockwave Medical Inc

Becton Dickinson and Co

Avinger Inc

Medtronic Plc

Boston Scientific Corp

Ra Medical Systems Inc

Johnson & Johnson

Abbott Laboratories